Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:39 AM UTC
| NCT Number | NCT07546500 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 420 participants |
| Active Locations | 11 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07546500 is currently recruiting participants. This clinical trial study for ovarian cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07546500 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07546500 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.